CTSO - CytoSorbents entered into separate agreements with InvoSurg Inc. and Surgical Partners to commercialize CytoSorb under its FDA EUA (Stock Price: 8.53)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.